klinische pädiatrie
130330
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Klinische Pädiatrie
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
More About This Journal
Editorial Board
Table of Contents
German National License
Imprint
Media
Authors
Instructions for Authors
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licensing
Job Board
Job Opportunities
PharmaMarket
PharmaMarket
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
Issues
Current Issue
Free Sample Issue (01/2024)
Related Books
Pädiatrie
Abstracts (HTML)
List of Authors
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
W
Y
Z
Ö
Aghaallaei, N
Altered extrinsic and intrinsic factors synergistically accelerate the thymic T-ALL development
Modelling congenital neutropenia, a pre-leukemic bone marrow failure syndrome in zebrafish
De novo design of growth factor inhibiting proteins
Albinger, N
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
Alejo, O
Identifying gene targets for drug repurposing to preventing myeloid malignancies
Alexe, G
Breaking the pump: targeting the sodium-potassium pump as a therapeutic strategy in acute myeloid leukemia
Alten, J
Prognostic significance of minimal residual disease prior to reinduction in intermediate risk patients with ALL
Prognostic relevance of persisting minimal residual disease in children with ALL and slow early response to chemotherapy
Amaral, AT
An innovative tailored CAR-T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma
Amend, D
Adapting CRISPR Cas9 dropout screens to in vivo PDX models of acute leukemias
Streamlining preclinical in vivo treatment trials by multiplexing genetically labelled PDX models in a single mouse
Mutations in KRAS and DNMT3A are not related to dependency in established tumors, in PDX acute leukemia model in vivo
Andrieux, G
Characterization of cooperating mechanisms in GATA2 syndrome
Identification of functional defects promoting leukemogenesis in GATA2-deficient individuals
Antunes, E
Understanding the role of ontogeny for the development of MLL-AF9 infant leukaemia
Armenteros-Monterroso, E
Establishing the mechanism for RUVBL2 essentiality in acute myeloid leukaemia
Ashtiani, M
Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation
Epigenetic modifiers direct lineage switch in MLL-AF4 leukemia
Autenrieb, M-P
Modulation of Daratumumab efficacy by Decitabine in pediatric T-cell lymphoblastic leukemia (T-ALL)
Baatz, F
CRISPR/Cas9-based generation of CAR-expressing natural killer-like cells against acute myeloid leukemia
Bader, P
ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma
Bagger, FO
Functional characterization of aberrant GATA1 protein complexes in normal and leukemic human erythroblasts
Bahrami, E
Adapting CRISPR Cas9 dropout screens to in vivo PDX models of acute leukemias
ADAM10’s sheddase function augments the interaction of leukemia cells with the bone marrow niche in PDX models in vivo
Bajoghli, B
Altered extrinsic and intrinsic factors synergistically accelerate the thymic T-ALL development
Modelling congenital neutropenia, a pre-leukemic bone marrow failure syndrome in zebrafish
Bajoghly, B
A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation
Bao, X
Mebendazole inhibits growth of hepatoblastoma cells by cell cycle arrest
Barbosa, T
Unravelling the recombinome of IKZF1 deletions in B-ALL
Barneh, F
Characterizing alternative splicing landscape by RUNX1/ETO reveals novel vulnerabilities in t(8;21) leukemia
Bastian, L
A meningeal preleukemic niche promotes the homing of B-cell Precursor Acute Lymphoblastic Leukaemia cells to the CNS
Bataller, A
A new T cell-redirecting strategy for the treatment of relapse/refractory T cell acute lymphoblastic leukemia
Bäuerle, T
CtDNA release mechanisms in a therapeutic Ewing Sarcoma mouse model
Baumann, N
Modulation of Daratumumab efficacy by Decitabine in pediatric T-cell lymphoblastic leukemia (T-ALL)
Becker, M
Mutations in KRAS and DNMT3A are not related to dependency in established tumors, in PDX acute leukemia model in vivo
ADAM10’s sheddase function augments the interaction of leukemia cells with the bone marrow niche in PDX models in vivo
Bentrop, M
Epigenetic perturbation by BMI-1 inhibitors as a novel therapeutic approach for hepatoblastoma
Benz, T
Designing specific chromosomal translocations of the MLL/KMT2A gene
Bertram, B
Prevention of relapse in juvenile myelomonocytic leukemia (JMML) by inhibition of immune checkpoint CD47
Bertrums, EJM
Mutational impact of chemotherapy on hematopoietic cells and evolution towards therapy-related pediatric AML
Bexte, T
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Bhayadia, R
Identifying gene targets for drug repurposing to preventing myeloid malignancies
CRISPRi proliferation and differentiation screening to identify functional long noncoding RNAs in pediatric AML
Blair, H
Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation
Understanding the FLT3-ITD maintenance and relapse pathways by RNAi screens
Ex vivo and in vivo complex drug combination analysis for improved efficacy and specificity in high-risk childhood acute lymphoblastic leukaemia
Blair, HJ
RUNX1/ETO effects on the interactions with t(8;21) AML with bone marrow niche: lessons from scRNAseq
Bock, T
Functional characterization of aberrant GATA1 protein complexes in normal and leukemic human erythroblasts
Bohler, S
Characterization of cooperating mechanisms in GATA2 syndrome
Bomken, S
Ex vivo and in vivo complex drug combination analysis for improved efficacy and specificity in high-risk childhood acute lymphoblastic leukaemia
Epigenetic modifiers direct lineage switch in MLL-AF4 leukemia
Bonifer, C
Understanding the FLT3-ITD maintenance and relapse pathways by RNAi screens
Bönig, H
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL
ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma
Borbarán-Bravo, N
A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation
Bornhauser, B
SOD2 Promotes Acute Leukemia Adaptation to Amino Acid Starvation Through the N-Degron Pathway
Börries, M
Characterization of cooperating mechanisms in GATA2 syndrome
Identification of functional defects promoting leukemogenesis in GATA2-deficient individuals
Botezatu, L
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Bourquin, J-P
SOD2 Promotes Acute Leukemia Adaptation to Amino Acid Starvation Through the N-Degron Pathway
Bräuer-Hartmann, D
Upstream regulation of DLK1-DIO3 locus in hematopoiesis and pediatric leukemia
Bräuning, S
A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation
Bueno, C
An innovative tailored CAR-T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma
Contribution of aneuploidy to the initiation and progression of childhood B-cell acute lymphoblastic leukemia
A single-cell expression atlas of human AML-LScs unravels the contribution of HIF pathway and its therapeutic potential
A new T cell-redirecting strategy for the treatment of relapse/refractory T cell acute lymphoblastic leukemia
Buettner, F
The proteogenomic subtypes of acute myeloid leukemia
Bultmann, M
A meningeal preleukemic niche promotes the homing of B-cell Precursor Acute Lymphoblastic Leukaemia cells to the CNS
Cairo, S
Mebendazole inhibits growth of hepatoblastoma cells by cell cycle arrest
Epigenetic perturbation by BMI-1 inhibitors as a novel therapeutic approach for hepatoblastoma
Cameron, R
Targeting the unique barcode of MLL/AF4
Campe, J
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Camps, J
Contribution of aneuploidy to the initiation and progression of childhood B-cell acute lymphoblastic leukemia
Cantilena, S
Drug repositioning for MLL-rearranged B-cell acute lymphoblastic leukaemia
Carcaboso, A
An innovative tailored CAR-T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma
Cario, G
Prognostic significance of minimal residual disease prior to reinduction in intermediate risk patients with ALL
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL
IKZF1plus under investigation: Optical Genome Mapping to detect additional alterations
Prognostic relevance of persisting minimal residual disease in children with ALL and slow early response to chemotherapy
Cathomen, T
A selection free ex vivo gene therapy approach to congenital neutropenia causing HAX1 mutations
Caye-Eude, A
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL
Cazzaniga, G
Unravelling the recombinome of IKZF1 deletions in B-ALL
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL
Charlotte, MN
Prevention of relapse in juvenile myelomonocytic leukemia (JMML) by inhibition of immune checkpoint CD47
Che, N
Drug repositioning for MLL-rearranged B-cell acute lymphoblastic leukaemia
Chetty, VK
Diagnostic and functional role of extracellular vesicles (EV) from blood and CSF in pediatric medulloblastoma (MB)
Cifarelli, LN
Deciphering the molecular mechanism of NUP98-KDM5A chromosomal translocation in pediatric non-DS-AMKL
Cinar, B
SOD2 Promotes Acute Leukemia Adaptation to Amino Acid Starvation Through the N-Degron Pathway
Closa, A
A single-cell expression atlas of human AML-LScs unravels the contribution of HIF pathway and its therapeutic potential
Coleman, D
Understanding the FLT3-ITD maintenance and relapse pathways by RNAi screens
Cremer, A
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Dannenmann, B
New Insights into the pathophysiology of cyclic neutropenia
A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation
A selection free ex vivo gene therapy approach to congenital neutropenia causing HAX1 mutations
HiPSC disease modelling to study leukemia development in HAX1 vs ELANE associated congenital neutropenia
de Boer, J
Drug repositioning for MLL-rearranged B-cell acute lymphoblastic leukaemia
de Kanter, JK
Mutational impact of chemotherapy on hematopoietic cells and evolution towards therapy-related pediatric AML
Demir, S
Mebendazole inhibits growth of hepatoblastoma cells by cell cycle arrest
Epigenetic perturbation by BMI-1 inhibitors as a novel therapeutic approach for hepatoblastoma
Deordieva, E
A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation
Derevyanko, PK
RUNX1/ETO effects on the interactions with t(8;21) AML with bone marrow niche: lessons from scRNAseq
Dharia, NV
Breaking the pump: targeting the sodium-potassium pump as a therapeutic strategy in acute myeloid leukemia
Dick, AM
Altered extrinsic and intrinsic factors synergistically accelerate the thymic T-ALL development
Dickel, N
Comprehensive bone marrow analysis integrating deep learning-based pattern discovery (BMDeep)
Dietterle, A
A meningeal preleukemic niche promotes the homing of B-cell Precursor Acute Lymphoblastic Leukaemia cells to the CNS
Dietz, A
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL
Doll, L
A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation
Modelling congenital neutropenia, a pre-leukemic bone marrow failure syndrome in zebrafish
Dörner, E
Identification of RBMS1 in the amplified region 2q24 as a major driver of cellular growth in childhood hepatoblastoma
Genetic landscape of large cell/anaplastic medulloblastoma – more than one disease
Dreschmann, V
Identification of RBMS1 in the amplified region 2q24 as a major driver of cellular growth in childhood hepatoblastoma
Duguid, A
Novel therapeutic avenues for MLL-AF4+ pro-B ALL patients based on a unique microRNA expression signature
Dzajic, E
Prognostic significance of minimal residual disease prior to reinduction in intermediate risk patients with ALL
Eckert, C
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL
Application of mediator probe PCR chemistry in multiplex target assays for monitoring MRD of high-risk neuroblastoma
Eder, T
Functional characterization of aberrant GATA1 protein complexes in normal and leukemic human erythroblasts
Identification of direct target genes of NUP98-KDM5A reveals regulatory gene networks in Acute Myeloid Leukemia
Egger, A
Application of mediator probe PCR chemistry in multiplex target assays for monitoring MRD of high-risk neuroblastoma
Eiblwieser, J
CtDNA release mechanisms in a therapeutic Ewing Sarcoma mouse model
ElGamacy, M
A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation
De novo design of cytokines, antikines, and novokines
De novo design of growth factor inhibiting proteins
Ellerkamp, V
Selinexor, a selective inhibitor of XPO-1, shows antitumor activity in rhabdomyosarcoma cell lines
Emerenciano, M
Unravelling the recombinome of IKZF1 deletions in B-ALL
Erlacher, M
Characterization of cooperating mechanisms in GATA2 syndrome
Identification of functional defects promoting leukemogenesis in GATA2-deficient individuals
Eyras, E
A single-cell expression atlas of human AML-LScs unravels the contribution of HIF pathway and its therapeutic potential
Fagnan, A
Functional characterization of aberrant GATA1 protein complexes in normal and leukemic human erythroblasts
Fan, Y
Mebendazole inhibits growth of hepatoblastoma cells by cell cycle arrest
Fazio, G
Unravelling the recombinome of IKZF1 deletions in B-ALL
Fernandez-Orth, J
Characterization of cooperating mechanisms in GATA2 syndrome
Identification of functional defects promoting leukemogenesis in GATA2-deficient individuals
Fillies, M
Application of mediator probe PCR chemistry in multiplex target assays for monitoring MRD of high-risk neuroblastoma
Forster, M
SOD2 Promotes Acute Leukemia Adaptation to Amino Acid Starvation Through the N-Degron Pathway
Frey, B
CtDNA release mechanisms in a therapeutic Ewing Sarcoma mouse model
Frietsch, AL
Application of mediator probe PCR chemistry in multiplex target assays for monitoring MRD of high-risk neuroblastoma
Fuchs, J
Different isolation techniques for isolation of extracellular vesicles
Selinexor, a selective inhibitor of XPO-1, shows antitumor activity in rhabdomyosarcoma cell lines
Gack, L
Deciphering the molecular mechanism of NUP98-KDM5A chromosomal translocation in pediatric non-DS-AMKL
Gao, Y
Mutations in KRAS and DNMT3A are not related to dependency in established tumors, in PDX acute leukemia model in vivo
Gasparoli, L
Establishing the mechanism for RUVBL2 essentiality in acute myeloid leukaemia
Gebel, V
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Gelehrt, CL
Modulation of Daratumumab efficacy by Decitabine in pediatric T-cell lymphoblastic leukemia (T-ALL)
Ghalandary, M
Mutations in KRAS and DNMT3A are not related to dependency in established tumors, in PDX acute leukemia model in vivo
Ghanam, J
Diagnostic and functional role of extracellular vesicles (EV) from blood and CSF in pediatric medulloblastoma (MB)
Giebel, B
Identification and isolation of homogenous AML derived extracellular vesicles for MRD detection in pediatric AML
Gierschek, F
Development of idiotype-specific vNAR-CAR-immune cells for the treatment of clonal malignancies
Goemans, BF
Mutational impact of chemotherapy on hematopoietic cells and evolution towards therapy-related pediatric AML
Gonzalez-Mendez, I
Identification of functional defects promoting leukemogenesis in GATA2-deficient individuals
Goschzik, T
Genetic landscape of large cell/anaplastic medulloblastoma – more than one disease
Grebien, F
Functional characterization of aberrant GATA1 protein complexes in normal and leukemic human erythroblasts
Identification of direct target genes of NUP98-KDM5A reveals regulatory gene networks in Acute Myeloid Leukemia
Grèze, V
Improving NK-cell immunotherapy against rhabdomyosarcoma
Grinev, V V
Epigenetic modifiers direct lineage switch in MLL-AF4 leukemia
Grinev, VV
Characterizing alternative splicing landscape by RUNX1/ETO reveals novel vulnerabilities in t(8;21) leukemia
Gutierrez, A
SOD2 Promotes Acute Leukemia Adaptation to Amino Acid Starvation Through the N-Degron Pathway
Habermann, J
Development of idiotype-specific vNAR-CAR-immune cells for the treatment of clonal malignancies
Haeupl, B
Breaking the pump: targeting the sodium-potassium pump as a therapeutic strategy in acute myeloid leukemia
Hagenbourger, F
Characterization of cooperating mechanisms in GATA2 syndrome
Hähnel, K
Clonal Hematopoiesis in Patients with Severe Congenital Neutropenia
Hartmann, M
Back to the roots – multi-omics as a road atlas to the cell-of-origin in rare childhood leukemia
Häselbarth, L
Targeting metabolism effectively complements tyrosine kinase inhibitor treatment of chronic myeloid leukemia
Häupl, B
The proteogenomic subtypes of acute myeloid leukemia
Heckl, D
Upstream regulation of DLK1-DIO3 locus in hematopoiesis and pediatric leukemia
A CRISPR-based platform to model AML progression using primary human cells
Identifying gene targets for drug repurposing to preventing myeloid malignancies
Deciphering the molecular mechanism of NUP98-KDM5A chromosomal translocation in pediatric non-DS-AMKL
CRISPRi proliferation and differentiation screening to identify functional long noncoding RNAs in pediatric AML
Hehir-Kwa, J
Epigenetic modifiers direct lineage switch in MLL-AF4 leukemia
Heidenreich, O
Efficient Expansion of Immature Acute Myeloid Leukaemia Cells in an Ex Vivo Co-culture System
Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation
Targeting the unique barcode of MLL/AF4
RUNX1/ETO effects on the interactions with t(8;21) AML with bone marrow niche: lessons from scRNAseq
Deep learning-based cell segmentation identifies T cell infiltration and spatial distribution in de novo pediatric AML
Understanding the FLT3-ITD maintenance and relapse pathways by RNAi screens
Ex vivo and in vivo complex drug combination analysis for improved efficacy and specificity in high-risk childhood acute lymphoblastic leukaemia
Characterizing alternative splicing landscape by RUNX1/ETO reveals novel vulnerabilities in t(8;21) leukemia
Epigenetic modifiers direct lineage switch in MLL-AF4 leukemia
Heim, C
ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma
Henssen, AG
Application of mediator probe PCR chemistry in multiplex target assays for monitoring MRD of high-risk neuroblastoma
Herbst, J
CRISPR/Cas9-based generation of CAR-expressing natural killer-like cells against acute myeloid leukemia
Hernandez, B
De novo design of cytokines, antikines, and novokines
Herold, T
Streamlining preclinical in vivo treatment trials by multiplexing genetically labelled PDX models in a single mouse
ADAM10’s sheddase function augments the interaction of leukemia cells with the bone marrow niche in PDX models in vivo
Hettich-Woggon, I
Clonal Hematopoiesis in Patients with Severe Congenital Neutropenia
Heyn, H
A single-cell expression atlas of human AML-LScs unravels the contribution of HIF pathway and its therapeutic potential
Hinze, L
SOD2 Promotes Acute Leukemia Adaptation to Amino Acid Starvation Through the N-Degron Pathway
Hoefler, L
Selinexor, a selective inhibitor of XPO-1, shows antitumor activity in rhabdomyosarcoma cell lines
Höfener, H
Comprehensive bone marrow analysis integrating deep learning-based pattern discovery (BMDeep)
Hudecek, M
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Hunt, K
Streamlining preclinical in vivo treatment trials by multiplexing genetically labelled PDX models in a single mouse
Hust, M
CRISPR/Cas9-based generation of CAR-expressing natural killer-like cells against acute myeloid leukemia
Ibrahim, NK
SOD2 Promotes Acute Leukemia Adaptation to Amino Acid Starvation Through the N-Degron Pathway
Ibuli, O
A meningeal preleukemic niche promotes the homing of B-cell Precursor Acute Lymphoblastic Leukaemia cells to the CNS
Irving, J
Ex vivo and in vivo complex drug combination analysis for improved efficacy and specificity in high-risk childhood acute lymphoblastic leukaemia
Issa, H
Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation
Upstream regulation of DLK1-DIO3 locus in hematopoiesis and pediatric leukemia
A CRISPR-based platform to model AML progression using primary human cells
Deciphering the molecular mechanism of NUP98-KDM5A chromosomal translocation in pediatric non-DS-AMKL
Ivics, Z
ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Jayavelu, AK
ADAM10’s sheddase function augments the interaction of leukemia cells with the bone marrow niche in PDX models in vivo
The proteogenomic subtypes of acute myeloid leukemia
Jeremias, I
Adapting CRISPR Cas9 dropout screens to in vivo PDX models of acute leukemias
A meningeal preleukemic niche promotes the homing of B-cell Precursor Acute Lymphoblastic Leukaemia cells to the CNS
Streamlining preclinical in vivo treatment trials by multiplexing genetically labelled PDX models in a single mouse
Mutations in KRAS and DNMT3A are not related to dependency in established tumors, in PDX acute leukemia model in vivo
ADAM10’s sheddase function augments the interaction of leukemia cells with the bone marrow niche in PDX models in vivo
Jovana, R
Prevention of relapse in juvenile myelomonocytic leukemia (JMML) by inhibition of immune checkpoint CD47
Jun, W
Prevention of relapse in juvenile myelomonocytic leukemia (JMML) by inhibition of immune checkpoint CD47
Jurinovic, V
ADAM10’s sheddase function augments the interaction of leukemia cells with the bone marrow niche in PDX models in vivo
Kandabarau, S
Clonal Hematopoiesis in Patients with Severe Congenital Neutropenia
Kappler, R
Mebendazole inhibits growth of hepatoblastoma cells by cell cycle arrest
Epigenetic perturbation by BMI-1 inhibitors as a novel therapeutic approach for hepatoblastoma
Karow, A
Targeting metabolism effectively complements tyrosine kinase inhibitor treatment of chronic myeloid leukemia
Kater, J
IKZF1plus under investigation: Optical Genome Mapping to detect additional alterations
Kaufmann, MM
A selection free ex vivo gene therapy approach to congenital neutropenia causing HAX1 mutations
Khalid, D
Breaking the pump: targeting the sodium-potassium pump as a therapeutic strategy in acute myeloid leukemia
Klimiankou, M
New Insights into the pathophysiology of cyclic neutropenia
A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation
Clonal Hematopoiesis in Patients with Severe Congenital Neutropenia
A selection free ex vivo gene therapy approach to congenital neutropenia causing HAX1 mutations
HiPSC disease modelling to study leukemia development in HAX1 vs ELANE associated congenital neutropenia
Klusmann, H J-
Deciphering the molecular mechanism of NUP98-KDM5A chromosomal translocation in pediatric non-DS-AMKL
Klusmann, J-H
Upstream regulation of DLK1-DIO3 locus in hematopoiesis and pediatric leukemia
A CRISPR-based platform to model AML progression using primary human cells
Identifying gene targets for drug repurposing to preventing myeloid malignancies
CRISPRi proliferation and differentiation screening to identify functional long noncoding RNAs in pediatric AML
ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma
Kock, F
Comprehensive bone marrow analysis integrating deep learning-based pattern discovery (BMDeep)
Koedijk, JB
Deep learning-based cell segmentation identifies T cell infiltration and spatial distribution in de novo pediatric AML
Koehler, R
Prognostic relevance of persisting minimal residual disease in children with ALL and slow early response to chemotherapy
Koekman, A
Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation
Kolmar, H
Development of idiotype-specific vNAR-CAR-immune cells for the treatment of clonal malignancies
Kooijmans, S
Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation
Kowarz, E
Designing specific chromosomal translocations of the MLL/KMT2A gene
MLL-r fusion transcripts in healthy individuals by induced gene proximity
Krause, K
Genetic landscape of large cell/anaplastic medulloblastoma – more than one disease
Kreyenberg, H
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
Krippner-Heidenreich, A
Efficient Expansion of Immature Acute Myeloid Leukaemia Cells in an Ex Vivo Co-culture System
Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation
Krumbholz, M
Targeting metabolism effectively complements tyrosine kinase inhibitor treatment of chronic myeloid leukemia
CtDNA release mechanisms in a therapeutic Ewing Sarcoma mouse model
Kühn, MWM
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
Külp, M
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL
Kunz, M
Comprehensive bone marrow analysis integrating deep learning-based pattern discovery (BMDeep)
Larghero, P
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL
Law, E
Ex vivo and in vivo complex drug combination analysis for improved efficacy and specificity in high-risk childhood acute lymphoblastic leukaemia
Lehnert, M
Application of mediator probe PCR chemistry in multiplex target assays for monitoring MRD of high-risk neuroblastoma
Lenk, L
A meningeal preleukemic niche promotes the homing of B-cell Precursor Acute Lymphoblastic Leukaemia cells to the CNS
Modulation of Daratumumab efficacy by Decitabine in pediatric T-cell lymphoblastic leukemia (T-ALL)
Lesch, MJ
Identification and isolation of homogenous AML derived extracellular vesicles for MRD detection in pediatric AML
Li, Q
Mebendazole inhibits growth of hepatoblastoma cells by cell cycle arrest
Looi-Somoye, R
Drug repositioning for MLL-rearranged B-cell acute lymphoblastic leukaemia
Lopes, B
Unravelling the recombinome of IKZF1 deletions in B-ALL
Loxha, L
SOD2 Promotes Acute Leukemia Adaptation to Amino Acid Starvation Through the N-Degron Pathway
Ludwig, R
Adapting CRISPR Cas9 dropout screens to in vivo PDX models of acute leukemias
Streamlining preclinical in vivo treatment trials by multiplexing genetically labelled PDX models in a single mouse
Lühmann, JL
IKZF1plus under investigation: Optical Genome Mapping to detect additional alterations
The extended potential of optical genome mapping (OGM) in pediatric AML compared to classical cytogenetics
Lunec, J
Ex vivo and in vivo complex drug combination analysis for improved efficacy and specificity in high-risk childhood acute lymphoblastic leukaemia
Lupas, AN
De novo design of cytokines, antikines, and novokines
De novo design of growth factor inhibiting proteins
Luque-Martin, R
Understanding the FLT3-ITD maintenance and relapse pathways by RNAi screens
Maciel, AL
Unravelling the recombinome of IKZF1 deletions in B-ALL
Maksymenko, K
De novo design of cytokines, antikines, and novokines
De novo design of growth factor inhibiting proteins
Malouf, C
Novel therapeutic avenues for MLL-AF4+ pro-B ALL patients based on a unique microRNA expression signature
Manhart, G
Identification of direct target genes of NUP98-KDM5A reveals regulatory gene networks in Acute Myeloid Leukemia
Mann, M
The proteogenomic subtypes of acute myeloid leukemia
Mansour, MR
Establishing the mechanism for RUVBL2 essentiality in acute myeloid leukaemia
Mardan, J
HiPSC disease modelling to study leukemia development in HAX1 vs ELANE associated congenital neutropenia
Marschalek, R
Designing specific chromosomal translocations of the MLL/KMT2A gene
MLL-r fusion transcripts in healthy individuals by induced gene proximity
Unravelling the recombinome of IKZF1 deletions in B-ALL
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL
Martens, JHA
Establishing the mechanism for RUVBL2 essentiality in acute myeloid leukaemia
Martínez, A
Contribution of aneuploidy to the initiation and progression of childhood B-cell acute lymphoblastic leukemia
Maschan, A
A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation
Mätzig, T
CRISPR/Cas9-based generation of CAR-expressing natural killer-like cells against acute myeloid leukemia
A multifunctional tracking approach to study clonal heterogeneity in leukemia by flow cytometry and scRNA-seq
Mayar, A
A meningeal preleukemic niche promotes the homing of B-cell Precursor Acute Lymphoblastic Leukaemia cells to the CNS
McKenzie, L
Ex vivo and in vivo complex drug combination analysis for improved efficacy and specificity in high-risk childhood acute lymphoblastic leukaemia
Mde Álava, E
An innovative tailored CAR-T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma
Meier, K
Identifying gene targets for drug repurposing to preventing myeloid malignancies
Menendez, P
An innovative tailored CAR-T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma
Contribution of aneuploidy to the initiation and progression of childhood B-cell acute lymphoblastic leukemia
A single-cell expression atlas of human AML-LScs unravels the contribution of HIF pathway and its therapeutic potential
A new T cell-redirecting strategy for the treatment of relapse/refractory T cell acute lymphoblastic leukemia
Menge, K
Deciphering the molecular mechanism of NUP98-KDM5A chromosomal translocation in pediatric non-DS-AMKL
Mercher, T
Functional characterization of aberrant GATA1 protein complexes in normal and leukemic human erythroblasts
Merker, M
ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma
Mertlitz, S
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Metzeler, K
Mutations in KRAS and DNMT3A are not related to dependency in established tumors, in PDX acute leukemia model in vivo
Metzler, M
Targeting metabolism effectively complements tyrosine kinase inhibitor treatment of chronic myeloid leukemia
CtDNA release mechanisms in a therapeutic Ewing Sarcoma mouse model
Comprehensive bone marrow analysis integrating deep learning-based pattern discovery (BMDeep)
Meyer, C
Unravelling the recombinome of IKZF1 deletions in B-ALL
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL
Meyer, J
CRISPR/Cas9-based generation of CAR-expressing natural killer-like cells against acute myeloid leukemia
Miriam, E
Prevention of relapse in juvenile myelomonocytic leukemia (JMML) by inhibition of immune checkpoint CD47
Miskey, C
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Möker, N
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
Molina, O
Contribution of aneuploidy to the initiation and progression of childhood B-cell acute lymphoblastic leukemia
A single-cell expression atlas of human AML-LScs unravels the contribution of HIF pathway and its therapeutic potential
Molnar, C
Identification of functional defects promoting leukemogenesis in GATA2-deficient individuals
Möricke, A
Prognostic significance of minimal residual disease prior to reinduction in intermediate risk patients with ALL
IKZF1plus under investigation: Optical Genome Mapping to detect additional alterations
Prognostic relevance of persisting minimal residual disease in children with ALL and slow early response to chemotherapy
Moser, LM
ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma
Mougiakaos, D
Targeting metabolism effectively complements tyrosine kinase inhibitor treatment of chronic myeloid leukemia
Müller, P
De novo design of growth factor inhibiting proteins
Münch, G
A meningeal preleukemic niche promotes the homing of B-cell Precursor Acute Lymphoblastic Leukaemia cells to the CNS
Nagel, L
CtDNA release mechanisms in a therapeutic Ewing Sarcoma mouse model
Nakjang, S
Epigenetic modifiers direct lineage switch in MLL-AF4 leukemia
Nasri, M
A selection free ex vivo gene therapy approach to congenital neutropenia causing HAX1 mutations
Nelson, R
Efficient Expansion of Immature Acute Myeloid Leukaemia Cells in an Ex Vivo Co-culture System
Niemeyer, CM
Characterization of cooperating mechanisms in GATA2 syndrome
Identification of functional defects promoting leukemogenesis in GATA2-deficient individuals
Nierkens, S
Deep learning-based cell segmentation identifies T cell infiltration and spatial distribution in de novo pediatric AML
Nofcz, L
Prognostic relevance of persisting minimal residual disease in children with ALL and slow early response to chemotherapy
Oberoi, P
Development of idiotype-specific vNAR-CAR-immune cells for the treatment of clonal malignancies
Oellerich, T
Breaking the pump: targeting the sodium-potassium pump as a therapeutic strategy in acute myeloid leukemia
The proteogenomic subtypes of acute myeloid leukemia
Oswald, B
HiPSC disease modelling to study leukemia development in HAX1 vs ELANE associated congenital neutropenia
Ottersbach, K
Novel therapeutic avenues for MLL-AF4+ pro-B ALL patients based on a unique microRNA expression signature
Understanding the role of ontogeny for the development of MLL-AF9 infant leukaemia
Palacios, AM
Development of idiotype-specific vNAR-CAR-immune cells for the treatment of clonal malignancies
Panisello, C
An innovative tailored CAR-T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma
Peipp, M
Modulation of Daratumumab efficacy by Decitabine in pediatric T-cell lymphoblastic leukemia (T-ALL)
Penack, O
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Petazzi, P
A new T cell-redirecting strategy for the treatment of relapse/refractory T cell acute lymphoblastic leukemia
Pfeifer, R
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
Pietsch, T
Identification of RBMS1 in the amplified region 2q24 as a major driver of cellular growth in childhood hepatoblastoma
Genetic landscape of large cell/anaplastic medulloblastoma – more than one disease
Pogozhykh, D
Clonal Hematopoiesis in Patients with Severe Congenital Neutropenia
Pontones, M
Comprehensive bone marrow analysis integrating deep learning-based pattern discovery (BMDeep)
Prommersberger, S
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Rajab, H
Different isolation techniques for isolation of extracellular vesicles
Rasouli, M
Targeting the unique barcode of MLL/AF4
Reetz, L
Diagnostic and functional role of extracellular vesicles (EV) from blood and CSF in pediatric medulloblastoma (MB)
Regenyi, E
Upstream regulation of DLK1-DIO3 locus in hematopoiesis and pediatric leukemia
Reindl, LM
Improving NK-cell immunotherapy against rhabdomyosarcoma
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Reinhardt, D
Identification and isolation of homogenous AML derived extracellular vesicles for MRD detection in pediatric AML
Diagnostic and functional role of extracellular vesicles (EV) from blood and CSF in pediatric medulloblastoma (MB)
The extended potential of optical genome mapping (OGM) in pediatric AML compared to classical cytogenetics
Rettinger, E
ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Ritter, MU
A selection free ex vivo gene therapy approach to congenital neutropenia causing HAX1 mutations
Rodemann, M
Identification of RBMS1 in the amplified region 2q24 as a major driver of cellular growth in childhood hepatoblastoma
Rodríguez-Cortez, V
Contribution of aneuploidy to the initiation and progression of childhood B-cell acute lymphoblastic leukemia
Rosendahl-Huber, AKM
Mutational impact of chemotherapy on hematopoietic cells and evolution towards therapy-related pediatric AML
Rothenberg-Thurley, M
Mutations in KRAS and DNMT3A are not related to dependency in established tumors, in PDX acute leukemia model in vivo
Sánchez-Martínez, D
A new T cell-redirecting strategy for the treatment of relapse/refractory T cell acute lymphoblastic leukemia
Särchen, V
Improving NK-cell immunotherapy against rhabdomyosarcoma
Sauer, MG
CRISPR/Cas9-based generation of CAR-expressing natural killer-like cells against acute myeloid leukemia
Saul, D
Targeting metabolism effectively complements tyrosine kinase inhibitor treatment of chronic myeloid leukemia
Schambach, A
CRISPR/Cas9-based generation of CAR-expressing natural killer-like cells against acute myeloid leukemia
Scheich, S
Breaking the pump: targeting the sodium-potassium pump as a therapeutic strategy in acute myeloid leukemia
Schewe, D M
A meningeal preleukemic niche promotes the homing of B-cell Precursor Acute Lymphoblastic Leukaemia cells to the CNS
Schewe, DM
Modulation of Daratumumab efficacy by Decitabine in pediatric T-cell lymphoblastic leukemia (T-ALL)
Schiffelers, R
Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation
Schlegelberger, B
IKZF1plus under investigation: Optical Genome Mapping to detect additional alterations
Schmell, A-L
Identifying gene targets for drug repurposing to preventing myeloid malignancies
Schmid, E
Different isolation techniques for isolation of extracellular vesicles
Selinexor, a selective inhibitor of XPO-1, shows antitumor activity in rhabdomyosarcoma cell lines
Schmid, JP
ADAM10’s sheddase function augments the interaction of leukemia cells with the bone marrow niche in PDX models in vivo
Schmoellerl, J
Identification of direct target genes of NUP98-KDM5A reveals regulatory gene networks in Acute Myeloid Leukemia
Schneider, C
Breaking the pump: targeting the sodium-potassium pump as a therapeutic strategy in acute myeloid leukemia
The proteogenomic subtypes of acute myeloid leukemia
Schneider, D
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
Schneider, M
The extended potential of optical genome mapping (OGM) in pediatric AML compared to classical cytogenetics
Schoenfeld, K
Development of idiotype-specific vNAR-CAR-immune cells for the treatment of clonal malignancies
Schrappe, M
Prognostic significance of minimal residual disease prior to reinduction in intermediate risk patients with ALL
IKZF1plus under investigation: Optical Genome Mapping to detect additional alterations
Prognostic relevance of persisting minimal residual disease in children with ALL and slow early response to chemotherapy
Schreek, S
SOD2 Promotes Acute Leukemia Adaptation to Amino Acid Starvation Through the N-Degron Pathway
Schroeer, A
Application of mediator probe PCR chemistry in multiplex target assays for monitoring MRD of high-risk neuroblastoma
Schubert, R
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Schulte, J
Application of mediator probe PCR chemistry in multiplex target assays for monitoring MRD of high-risk neuroblastoma
Schultheis, L
Different isolation techniques for isolation of extracellular vesicles
Schuschel, K
Deciphering the molecular mechanism of NUP98-KDM5A chromosomal translocation in pediatric non-DS-AMKL
Schwaller, J
Understanding the role of ontogeny for the development of MLL-AF9 infant leukaemia
Functional characterization of aberrant GATA1 protein complexes in normal and leukemic human erythroblasts
Schweighart, EK
Epigenetic modifiers direct lineage switch in MLL-AF4 leukemia
Schwen, L
Comprehensive bone marrow analysis integrating deep learning-based pattern discovery (BMDeep)
Seinen, C
Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation
Semper, S
CtDNA release mechanisms in a therapeutic Ewing Sarcoma mouse model
Serve, H
The proteogenomic subtypes of acute myeloid leukemia
Shcherbina, A
A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation
Singh, M
Ex vivo and in vivo complex drug combination analysis for improved efficacy and specificity in high-risk childhood acute lymphoblastic leukaemia
Sivalingam, R
Functional characterization of aberrant GATA1 protein complexes in normal and leukemic human erythroblasts
Skokowa, J
New Insights into the pathophysiology of cyclic neutropenia
A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation
Modelling congenital neutropenia, a pre-leukemic bone marrow failure syndrome in zebrafish
De novo design of cytokines, antikines, and novokines
Clonal Hematopoiesis in Patients with Severe Congenital Neutropenia
A selection free ex vivo gene therapy approach to congenital neutropenia causing HAX1 mutations
De novo design of growth factor inhibiting proteins
HiPSC disease modelling to study leukemia development in HAX1 vs ELANE associated congenital neutropenia
Solovyeva, A
HiPSC disease modelling to study leukemia development in HAX1 vs ELANE associated congenital neutropenia
Spaink, H
Breaking the pump: targeting the sodium-potassium pump as a therapeutic strategy in acute myeloid leukemia
Stanulla, M
IKZF1plus under investigation: Optical Genome Mapping to detect additional alterations
SOD2 Promotes Acute Leukemia Adaptation to Amino Acid Starvation Through the N-Degron Pathway
Steding, H
A multifunctional tracking approach to study clonal heterogeneity in leukemia by flow cytometry and scRNA-seq
Stegmaier, K
Breaking the pump: targeting the sodium-potassium pump as a therapeutic strategy in acute myeloid leukemia
Steinemann, D
IKZF1plus under investigation: Optical Genome Mapping to detect additional alterations
The extended potential of optical genome mapping (OGM) in pediatric AML compared to classical cytogenetics
Streb, P
MLL-r fusion transcripts in healthy individuals by induced gene proximity
Stückle, J
Different isolation techniques for isolation of extracellular vesicles
Sutton, R
Unravelling the recombinome of IKZF1 deletions in B-ALL
Suttorp, J
The extended potential of optical genome mapping (OGM) in pediatric AML compared to classical cytogenetics
Swart, L
Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation
Targeting the unique barcode of MLL/AF4
Swart, LE
RUNX1/ETO effects on the interactions with t(8;21) AML with bone marrow niche: lessons from scRNAseq
Szoltysek, K
Ex vivo and in vivo complex drug combination analysis for improved efficacy and specificity in high-risk childhood acute lymphoblastic leukaemia
Epigenetic modifiers direct lineage switch in MLL-AF4 leukemia
Szymansky, A
Application of mediator probe PCR chemistry in multiplex target assays for monitoring MRD of high-risk neuroblastoma
Tauchmann, S
Functional characterization of aberrant GATA1 protein complexes in normal and leukemic human erythroblasts
Teichert-von Lüttichau, I
Identification of functional defects promoting leukemogenesis in GATA2-deficient individuals
Thakur, BK
Identification and isolation of homogenous AML derived extracellular vesicles for MRD detection in pediatric AML
Diagnostic and functional role of extracellular vesicles (EV) from blood and CSF in pediatric medulloblastoma (MB)
Thampi, N
Contribution of aneuploidy to the initiation and progression of childhood B-cell acute lymphoblastic leukemia
Tirado, N
A new T cell-redirecting strategy for the treatment of relapse/refractory T cell acute lymphoblastic leukemia
Tirtakusuma, R
Epigenetic modifiers direct lineage switch in MLL-AF4 leukemia
Trincado, JL
A single-cell expression atlas of human AML-LScs unravels the contribution of HIF pathway and its therapeutic potential
A new T cell-redirecting strategy for the treatment of relapse/refractory T cell acute lymphoblastic leukemia
Troester, S
Identification of direct target genes of NUP98-KDM5A reveals regulatory gene networks in Acute Myeloid Leukemia
Tsingos, E
Altered extrinsic and intrinsic factors synergistically accelerate the thymic T-ALL development
Tuk, D
Efficient Expansion of Immature Acute Myeloid Leukaemia Cells in an Ex Vivo Co-culture System
Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation
Ullrich, E
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
Development of idiotype-specific vNAR-CAR-immune cells for the treatment of clonal malignancies
Improving NK-cell immunotherapy against rhabdomyosarcoma
ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Ullrich, T
De novo design of cytokines, antikines, and novokines
Valerius, T
Modulation of Daratumumab efficacy by Decitabine in pediatric T-cell lymphoblastic leukemia (T-ALL)
van Boxtel, R
Mutational impact of chemotherapy on hematopoietic cells and evolution towards therapy-related pediatric AML
van den Heuvel-Eibrink, MM
Mutational impact of chemotherapy on hematopoietic cells and evolution towards therapy-related pediatric AML
Van der Werf, I
Deep learning-based cell segmentation identifies T cell infiltration and spatial distribution in de novo pediatric AML
van Oort, A
Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation
Characterizing alternative splicing landscape by RUNX1/ETO reveals novel vulnerabilities in t(8;21) leukemia
Velasco-Hernandez, T
A single-cell expression atlas of human AML-LScs unravels the contribution of HIF pathway and its therapeutic potential
Velten, L
A single-cell expression atlas of human AML-LScs unravels the contribution of HIF pathway and its therapeutic potential
Venn, NC
Unravelling the recombinome of IKZF1 deletions in B-ALL
Verboon, L
Upstream regulation of DLK1-DIO3 locus in hematopoiesis and pediatric leukemia
Vermeulen, MA
Deep learning-based cell segmentation identifies T cell infiltration and spatial distribution in de novo pediatric AML
Vick, B
Streamlining preclinical in vivo treatment trials by multiplexing genetically labelled PDX models in a single mouse
ADAM10’s sheddase function augments the interaction of leukemia cells with the bone marrow niche in PDX models in vivo
Vinyoles, M
Contribution of aneuploidy to the initiation and progression of childhood B-cell acute lymphoblastic leukemia
A single-cell expression atlas of human AML-LScs unravels the contribution of HIF pathway and its therapeutic potential
Virely, C
Establishing the mechanism for RUVBL2 essentiality in acute myeloid leukaemia
Vogiatzi, F
Modulation of Daratumumab efficacy by Decitabine in pediatric T-cell lymphoblastic leukemia (T-ALL)
Vogler, M
Improving NK-cell immunotherapy against rhabdomyosarcoma
Vokuhl, C
Identification of RBMS1 in the amplified region 2q24 as a major driver of cellular growth in childhood hepatoblastoma
von Lindern, M
Functional characterization of aberrant GATA1 protein complexes in normal and leukemic human erythroblasts
von Neuhoff, N
The extended potential of optical genome mapping (OGM) in pediatric AML compared to classical cytogenetics
von Schweinitz, D
Identification of RBMS1 in the amplified region 2q24 as a major driver of cellular growth in childhood hepatoblastoma
Vormoor, J
Ex vivo and in vivo complex drug combination analysis for improved efficacy and specificity in high-risk childhood acute lymphoblastic leukaemia
Wagner, A
Mebendazole inhibits growth of hepatoblastoma cells by cell cycle arrest
Walte, K
Modelling congenital neutropenia, a pre-leukemic bone marrow failure syndrome in zebrafish
Warmann, SW
Different isolation techniques for isolation of extracellular vesicles
Weiss, JM
Characterization of cooperating mechanisms in GATA2 syndrome
Identification of functional defects promoting leukemogenesis in GATA2-deficient individuals
Wels, WS
Development of idiotype-specific vNAR-CAR-immune cells for the treatment of clonal malignancies
Improving NK-cell immunotherapy against rhabdomyosarcoma
ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Welte, K
New Insights into the pathophysiology of cyclic neutropenia
A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation
Clonal Hematopoiesis in Patients with Severe Congenital Neutropenia
A selection free ex vivo gene therapy approach to congenital neutropenia causing HAX1 mutations
HiPSC disease modelling to study leukemia development in HAX1 vs ELANE associated congenital neutropenia
Wendeburg, L
IKZF1plus under investigation: Optical Genome Mapping to detect additional alterations
Wendel, P
Development of idiotype-specific vNAR-CAR-immune cells for the treatment of clonal malignancies
Improving NK-cell immunotherapy against rhabdomyosarcoma
Westphal, M
Comprehensive bone marrow analysis integrating deep learning-based pattern discovery (BMDeep)
Williams, O
Drug repositioning for MLL-rearranged B-cell acute lymphoblastic leukaemia
Establishing the mechanism for RUVBL2 essentiality in acute myeloid leukaemia
Winkler, A
Application of mediator probe PCR chemistry in multiplex target assays for monitoring MRD of high-risk neuroblastoma
Winkler, R
CRISPRi proliferation and differentiation screening to identify functional long noncoding RNAs in pediatric AML
Winter, G
Identification of direct target genes of NUP98-KDM5A reveals regulatory gene networks in Acute Myeloid Leukemia
Winterberg, D
A meningeal preleukemic niche promotes the homing of B-cell Precursor Acute Lymphoblastic Leukaemia cells to the CNS
Modulation of Daratumumab efficacy by Decitabine in pediatric T-cell lymphoblastic leukemia (T-ALL)
Wirth, AK
Streamlining preclinical in vivo treatment trials by multiplexing genetically labelled PDX models in a single mouse
ADAM10’s sheddase function augments the interaction of leukemia cells with the bone marrow niche in PDX models in vivo
Wolf, S
Modulation of Daratumumab efficacy by Decitabine in pediatric T-cell lymphoblastic leukemia (T-ALL)
The proteogenomic subtypes of acute myeloid leukemia
Yigit, BI
Identification of functional defects promoting leukemogenesis in GATA2-deficient individuals
Zeidler, A
New Insights into the pathophysiology of cyclic neutropenia
Zeidler, C
New Insights into the pathophysiology of cyclic neutropenia
A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation
Clonal Hematopoiesis in Patients with Severe Congenital Neutropenia
A selection free ex vivo gene therapy approach to congenital neutropenia causing HAX1 mutations
HiPSC disease modelling to study leukemia development in HAX1 vs ELANE associated congenital neutropenia
Zeidler, KA
A selection free ex vivo gene therapy approach to congenital neutropenia causing HAX1 mutations
Zhang, C
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
Zimmermann, M
Prognostic significance of minimal residual disease prior to reinduction in intermediate risk patients with ALL
Prognostic relevance of persisting minimal residual disease in children with ALL and slow early response to chemotherapy
Zuber, J
Identification of direct target genes of NUP98-KDM5A reveals regulatory gene networks in Acute Myeloid Leukemia
Zwaan, CM
Mutational impact of chemotherapy on hematopoietic cells and evolution towards therapy-related pediatric AML
Zwaan, M C
Deep learning-based cell segmentation identifies T cell infiltration and spatial distribution in de novo pediatric AML
Öllinger, R
ADAM10’s sheddase function augments the interaction of leukemia cells with the bone marrow niche in PDX models in vivo